rs2111119

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_015272.5(RPGRIP1L):​c.3073G>A​(p.Gly1025Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0969 in 1,611,706 control chromosomes in the GnomAD database, including 9,243 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.11 ( 1140 hom., cov: 32)
Exomes 𝑓: 0.095 ( 8103 hom. )

Consequence

RPGRIP1L
NM_015272.5 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 1.51

Publications

37 publications found
Variant links:
Genes affected
RPGRIP1L (HGNC:29168): (RPGRIP1 like) The protein encoded by this gene can localize to the basal body-centrosome complex or to primary cilia and centrosomes in ciliated cells. The encoded protein has been found to interact with nephrocystin-4. Defects in this gene are a cause of Joubert syndrome type 7 (JBTS7) and Meckel syndrome type 5 (MKS5). [provided by RefSeq, Jun 2016]
RPGRIP1L Gene-Disease associations (from GenCC):
  • Meckel syndrome, type 5
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • Joubert syndrome 7
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • COACH syndrome 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Joubert syndrome with renal defect
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Meckel syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004034281).
BP6
Variant 16-53637842-C-T is Benign according to our data. Variant chr16-53637842-C-T is described in ClinVar as Benign. ClinVar VariationId is 126277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.296 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RPGRIP1LNM_015272.5 linkc.3073G>A p.Gly1025Ser missense_variant Exon 21 of 27 ENST00000647211.2 NP_056087.2 Q68CZ1-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RPGRIP1LENST00000647211.2 linkc.3073G>A p.Gly1025Ser missense_variant Exon 21 of 27 NM_015272.5 ENSP00000493946.1 Q68CZ1-1

Frequencies

GnomAD3 genomes
AF:
0.111
AC:
16938
AN:
151960
Hom.:
1134
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.158
Gnomad AMI
AF:
0.0724
Gnomad AMR
AF:
0.0835
Gnomad ASJ
AF:
0.136
Gnomad EAS
AF:
0.309
Gnomad SAS
AF:
0.143
Gnomad FIN
AF:
0.0482
Gnomad MID
AF:
0.108
Gnomad NFE
AF:
0.0812
Gnomad OTH
AF:
0.121
GnomAD2 exomes
AF:
0.112
AC:
28086
AN:
250566
AF XY:
0.110
show subpopulations
Gnomad AFR exome
AF:
0.159
Gnomad AMR exome
AF:
0.0904
Gnomad ASJ exome
AF:
0.146
Gnomad EAS exome
AF:
0.321
Gnomad FIN exome
AF:
0.0528
Gnomad NFE exome
AF:
0.0809
Gnomad OTH exome
AF:
0.101
GnomAD4 exome
AF:
0.0954
AC:
139258
AN:
1459628
Hom.:
8103
Cov.:
32
AF XY:
0.0961
AC XY:
69800
AN XY:
726206
show subpopulations
African (AFR)
AF:
0.155
AC:
5191
AN:
33404
American (AMR)
AF:
0.0886
AC:
3960
AN:
44678
Ashkenazi Jewish (ASJ)
AF:
0.144
AC:
3756
AN:
26102
East Asian (EAS)
AF:
0.280
AC:
11098
AN:
39592
South Asian (SAS)
AF:
0.137
AC:
11842
AN:
86212
European-Finnish (FIN)
AF:
0.0550
AC:
2904
AN:
52842
Middle Eastern (MID)
AF:
0.110
AC:
633
AN:
5758
European-Non Finnish (NFE)
AF:
0.0838
AC:
93104
AN:
1110730
Other (OTH)
AF:
0.112
AC:
6770
AN:
60310
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.454
Heterozygous variant carriers
0
6255
12510
18766
25021
31276
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3686
7372
11058
14744
18430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.112
AC:
16959
AN:
152078
Hom.:
1140
Cov.:
32
AF XY:
0.110
AC XY:
8162
AN XY:
74310
show subpopulations
African (AFR)
AF:
0.158
AC:
6545
AN:
41478
American (AMR)
AF:
0.0838
AC:
1280
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.136
AC:
470
AN:
3462
East Asian (EAS)
AF:
0.309
AC:
1594
AN:
5158
South Asian (SAS)
AF:
0.143
AC:
689
AN:
4822
European-Finnish (FIN)
AF:
0.0482
AC:
510
AN:
10584
Middle Eastern (MID)
AF:
0.0952
AC:
28
AN:
294
European-Non Finnish (NFE)
AF:
0.0812
AC:
5519
AN:
67982
Other (OTH)
AF:
0.122
AC:
258
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
766
1532
2299
3065
3831
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
198
396
594
792
990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0972
Hom.:
3979
Bravo
AF:
0.117
TwinsUK
AF:
0.0806
AC:
299
ALSPAC
AF:
0.0851
AC:
328
ESP6500AA
AF:
0.157
AC:
688
ESP6500EA
AF:
0.0865
AC:
744
ExAC
AF:
0.114
AC:
13893
Asia WGS
AF:
0.232
AC:
804
AN:
3476
EpiCase
AF:
0.0855
EpiControl
AF:
0.0860

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 27, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Joubert syndrome 7 Benign:2
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Meckel syndrome, type 5 Benign:2
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Joubert syndrome Benign:1
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nephronophthisis 8 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Meckel-Gruber syndrome;C0431399:Joubert syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.061
BayesDel_addAF
Benign
-0.63
T
BayesDel_noAF
Benign
-0.54
CADD
Benign
14
DANN
Benign
0.19
DEOGEN2
Benign
0.0021
.;.;T;.;.;.
Eigen
Benign
-0.95
Eigen_PC
Benign
-0.77
FATHMM_MKL
Benign
0.0058
N
LIST_S2
Benign
0.13
T;.;T;T;T;T
MetaRNN
Benign
0.0040
T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-1.2
.;N;.;N;.;.
PhyloP100
1.5
PrimateAI
Benign
0.27
T
PROVEAN
Benign
1.2
N;.;.;N;N;N
REVEL
Benign
0.21
Sift
Benign
1.0
T;.;.;T;T;T
Sift4G
Benign
0.82
T;.;T;T;T;T
Polyphen
0.0
B;B;.;B;.;.
Vest4
0.029
MPC
0.072
ClinPred
0.00058
T
GERP RS
3.0
Varity_R
0.030
gMVP
0.12
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2111119; hg19: chr16-53671754; COSMIC: COSV50903572; API